Sector | Healthcare | Compare with Sector peers |
Industry | Pharmaceuticals & Drugs | Compare with Industry peers |
Website | http://www.pghealthindia.com | |
Market Cap | 7,832.17 Cr. | |
Enterprise Value(EV) | 7,406.61 Cr. | 2023-12 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 136.54 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | 34.56 | Trailing Twelve Months Ending 2023-12 |
Industry PE | 41.15 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 485.49 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 9.72 | Calculated using Price: 4,718.35 |
Dividend Yield | 2.01 | Period Ending 2023-06 |
No. of Shares Subscribed | 1.66 Cr. | 16,599,382 Shares |
FaceValue | 10 | |
About Procter & Gamble Health Ltd. | ||
Till 2018, the Company was operating in all businesses included in the pharmaceuticals and chemicals businesses in the country. The company is one of India's largest VMS Companies manufacturing and marketing over-the-counter products, vitamins, minerals, and supplements products for a healthy lifestyle and improved quality of life. Its trusted products are household names in India protecting and supporting millions of people at every stage of life. |
1 Day |
|
+0.53% |
1 Week |
|
-1.36% |
1 Month |
|
-3.39% |
3 Month |
|
-9.40% |
6 Month |
|
-8.27% |
1 Year |
|
-3.06% |
2 Year |
|
+9.51% |
5 Year |
|
+20.73% |
10 Year |
|
+607.83% |
9 years | 2014-12 | 2015-12 | 2016-12 | 2017-12 | 2018-12 | 2020-06 | 2021-06 | 2022-06 | 2023-06 | |
Return on Equity (%) | 8.02 | 9.35 | 12.61 | 8.74 | 8.95 | 20.79 | 22.04 | 29.41 | 33.94 | |
Return on Capital Employed (%) | 12.36 | 14.54 | 18.35 | 14.16 | 13.9 | 29.01 | 29.08 | 38.45 | 46.07 | |
Return on Assets (%) | 4.37 | 3.92 | 5.48 | 4.24 | 4.96 | 10.82 | 8.65 | 9.83 | 11 |
Particulars | 10 years | 2014-12 Rs. Cr. | 2015-12 Rs. Cr. | 2016-12 Rs. Cr. | 2017-12 Rs. Cr. | 2018-12 Rs. Cr. | 2020-06 Rs. Cr. | 2021-06 Rs. Cr. | 2022-06 Rs. Cr. | 2023-06 Rs. Cr. | 2023-12* Rs. Cr. |
Shh. Funds | 554 | 592 | 664 | 733 | 1,540 | 906 | 704 | 616 | 751 | 806 | |
Non Curr. Liab. | 390 | 395 | 399 | 431 | 495 | 667 | 723 | 714 | 803 | 14 | |
Curr. Liab. | 260 | 539 | 301 | 352 | 548 | 539 | 551 | 608 | 679 | 231 | |
Minority Int. | |||||||||||
Equity & Liab. | 1,204 | 1,525 | 1,363 | 1,516 | 2,583 | 2,112 | 1,978 | 1,938 | 2,233 | 1,050 | |
Non Curr. Assets | 581 | 579 | 613 | 637 | 693 | 847 | 939 | 954 | 1,062 | 279 | |
Curr. Assets | 623 | 946 | 750 | 879 | 1,889 | 1,265 | 1,039 | 984 | 1,171 | 771 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 1,204 | 1,525 | 1,363 | 1,516 | 2,583 | 2,112 | 1,978 | 1,938 | 2,233 | 1,050 |
Particulars | 10 years | 2014-12 Rs. Cr. | 2015-12 Rs. Cr. | 2016-12 Rs. Cr. | 2017-12 Rs. Cr. | 2018-12 Rs. Cr. | 2020-06 Rs. Cr. | 2021-06 Rs. Cr. | 2022-06 Rs. Cr. | 2023-06 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 867 | 940 | 993 | 698 | 849 | 1,356 | 1,009 | 1,114 | 1,230 | 1,237 | |
Other Income | 20 | 23 | 24 | 30 | 28 | 70 | 18 | 13 | 18 | 22 | |
Total Income | 888 | 963 | 1,017 | 729 | 877 | 1,426 | 1,027 | 1,128 | 1,248 | 1,259 | |
Total Expenditure | -809 | -856 | -877 | -628 | -705 | -1,042 | -763 | -847 | -905 | -922 | |
PBIDT | 79 | 107 | 140 | 101 | 173 | 384 | 264 | 281 | 343 | 337 | |
Interest | -1 | 0 | -1 | -1 | |||||||
Depreciation | -13 | -23 | -25 | -19 | -21 | -29 | -30 | -27 | -28 | -26 | |
Taxation | -23 | -30 | -36 | -38 | -56 | -101 | -56 | -61 | -85 | -84 | |
Exceptional Items | 17 | 7 | |||||||||
PAT | 43 | 54 | 79 | 61 | 102 | 254 | 177 | 193 | 229 | 227 | |
Adjusted EPS | 26 | 32 | 48 | 37 | 61 | 153 | 107 | 116 | 138 | 137 |
Particulars | 10 years | 2013-12 Rs. Cr. | 2014-12 Rs. Cr. | 2015-12 Rs. Cr. | 2016-12 Rs. Cr. | 2017-12 Rs. Cr. | 2018-12 Rs. Cr. | 2020-06 Rs. Cr. | 2021-06 Rs. Cr. | 2022-06 Rs. Cr. | 2023-06 Rs. Cr. |
Cash Fr. Operatn. | 0 | 5 | 83 | 107 | 54 | -130 | 235 | 247 | 170 | 236 | |
Cash Fr. Inv. | 7 | 11 | -68 | -75 | -48 | 1,270 | 165 | -32 | -26 | -22 | |
Cash Fr. Finan. | -5 | -17 | -12 | -15 | -22 | -30 | -883 | -387 | -289 | -98 | |
Net Change | 3 | -1 | 4 | 17 | -16 | 1,109 | -483 | -172 | -145 | 116 | |
Cash & Cash Eqvt | 7 | 5 | 9 | 26 | 10 | 1,119 | 636 | 464 | 319 | 435 |
Wed, 17 Apr 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Dear Sir We have received intimation from our shareholder regarding loss of share certificate as detailed in enclosed letter. Request you to kindly take note of the same. |
Fri, 12 Apr 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Dear Sir Please find attached report received from RTA confirming compliance under Regulation 74 of the SEBI (DP) Regulations 2018. Kindly take the same on record. |
Fri, 12 Apr 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Dear Sir This is to update that we have issued duplicate share certificates to our shareholders as detailed in enclosed letter. Kindly take note of the same. |
Tue, 16 Apr 2024 |
Close Within 52 Week Low Zone |
William %R Bullish |
CCI Oversold Zone |
MFI Below 20 |
Close Below Last Week Low |